Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChronicleBio
United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ChronicleBio develops an advanced, AI-ready data and biobank platform integrating clinical, molecular, multi-omics, patient-reported, and real-world data for neuroimmune and chronic conditions; the platform supports biomarker discovery, patient stratification, and drug development, and is now in use for research and clinical trial readiness at multiple clinics in the US and India, with ongoing partnerships for further expansion.
- Therapeutic areas
- Infectious DiseasesCardiovascularNeurologyImmunology
- Industry
- Drug Discovery Services
02
Partnerships
Solve M.E.Brain Inflammation Collaborative (BIC)Complex Disorders AllianceCareEvolutionMultiple high-integrity clinics in the US and India
Beyond the preview
Go deeper on ChronicleBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ChronicleBio.